Cargando…

Evolving transcriptomic fingerprint based on genome‐wide data as prognostic tools in prostate cancer

BACKGROUND INFORMATION: Prostate cancer (PCa) is a common disease but only a small subset of patients are at risk of developing metastasis and lethal disease, and identifying which patients will progress is challenging because of the heterogeneity underlying tumour progression. Understanding this he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alshalalfa, Mohammed, Schliekelman, Mark, Shin, Heesun, Erho, Nicholas, Davicioni, Elai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744779/ https://www.ncbi.nlm.nih.gov/pubmed/25900404 http://dx.doi.org/10.1111/boc.201400097

Ejemplares similares

Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma
por: Tsai, Harrison K., et al.
Publicado: (2017)

Transcriptome-Wide Detection of Differentially Expressed Coding and Non-Coding Transcripts and Their Clinical Significance in Prostate Cancer
por: Erho, Nicholas, et al.
Publicado: (2012)

Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma
por: Alshalalfa, Mohammed, et al.
Publicado: (2019)

Development of a predictive model for stromal content in prostate cancer samples to improve signature performance
por: Boufaied, Nadia, et al.
Publicado: (2019)

Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1
por: Spans, Lien, et al.
Publicado: (2016)

Genomic “Dark Matter” in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers
por: Vergara, Ismael A., et al.
Publicado: (2012)

Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis
por: Lee, Hak J, et al.
Publicado: (2016)

Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies
por: Stoyanova, Radka, et al.
Publicado: (2016)

Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer
por: Liu, Deli, et al.
Publicado: (2018)

Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer
por: Mitra, Anirban P., et al.
Publicado: (2014)

Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer
por: Berglund, Anders E., et al.
Publicado: (2018)

Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies
por: Jäger, Wolfgang, et al.
Publicado: (2015)

Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report
por: Kim, Hyun, et al.
Publicado: (2016)

The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications
por: Ramnarine, Varune Rohan, et al.
Publicado: (2018)

Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer
por: Yang, Lingjian, et al.
Publicado: (2018)

Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients
por: Alshalalfa, Mohammed, et al.
Publicado: (2017)

Prostate Cancer Tumor Volume and Genomic Risk
por: Ramaswamy, Ashwin, et al.
Publicado: (2023)

The lncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer
por: Prensner, John R., et al.
Publicado: (2014)

Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapy
por: Handke, Analena, et al.
Publicado: (2023)

Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy
por: Erho, Nicholas, et al.
Publicado: (2013)

Metagenomic and metatranscriptomic analysis of human prostate microbiota from patients with prostate cancer
por: Feng, Ye, et al.
Publicado: (2019)

Diversity in Androgen Receptor Action Among Treatment-naïve Prostate Cancers Is Reflected in Treatment Response Predictions and Molecular Subtypes
por: Ben-Salem, Salma, et al.
Publicado: (2020)

MicroRNA Response Elements-Mediated miRNA-miRNA Interactions in Prostate Cancer
por: Alshalalfa, Mohammed
Publicado: (2012)

The Prognostic Potential of Human Prostate Cancer-Associated Macrophage Subtypes as Revealed by Single-Cell Transcriptomics
por: Siefert, Joseph C., et al.
Publicado: (2021)

Lipid degradation promotes prostate cancer cell survival
por: Itkonen, Harri M, et al.
Publicado: (2017)

Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery
por: Badani, Ketan K, et al.
Publicado: (2015)

Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race
por: Kensler, Kevin H., et al.
Publicado: (2022)

Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group
por: Badani, Ketan, et al.
Publicado: (2013)

High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program
por: Labbé, David P., et al.
Publicado: (2019)

High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer
por: Zhao, S G, et al.
Publicado: (2015)

Prostate cancer in young men represents a distinct clinical phenotype: gene expression signature to predict early metastases
por: Ding, Yuan C., et al.
Publicado: (2021)

Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer
por: Severson, Tesa, et al.
Publicado: (2022)

The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer
por: Chakravarty, Dimple, et al.
Publicado: (2014)

Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance
por: Nouri, Mannan, et al.
Publicado: (2017)

Raman fingerprint for semi-metal WTe(2) evolving from bulk to monolayer
por: Jiang, Y. C., et al.
Publicado: (2016)

Proteomic profiling of the tumor microenvironment: recent insights and the search for biomarkers
por: Hanash, Sam, et al.
Publicado: (2014)

Coordinate MicroRNA-Mediated Regulation of Protein Complexes in Prostate Cancer
por: Alshalalfa, Mohammed, et al.
Publicado: (2013)

Multi-ethnic transcriptome-wide association study of prostate cancer
por: Fiorica, Peter N., et al.
Publicado: (2020)

The transcriptomic fingerprint of glucoamylase over-expression in Aspergillus niger
por: Kwon, Min Jin, et al.
Publicado: (2012)

Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrence
por: Ku, Anson T., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_shci3k335lckbfinf0fr1j8vfd